Legal status · United States
Is Linaclotide legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Linaclotide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Linaclotide in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Approved for irritable bowel syndrome with constipation and chronic idiopathic constipation. Boxed warning contraindicating use in children under two years due to risk of serious dehydration. |
| FDA approval status | FDA-approved as Linzess for irritable bowel syndrome with constipation and for chronic idiopathic constipation in adults, and for functional constipation in children. Carries a boxed warning against use in children under two years because of a risk of serious dehydration. |
| Human studies cited | 1 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Linaclotide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Linaclotide for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Linaclotide is
A 14-amino-acid peptide taken orally that works without being absorbed, acting entirely on receptors in the gut lining. Approved on randomised phase 3 trials for constipation.
Linaclotide is the most interesting design on this page and the reason is counterintuitive: it is an oral peptide that works precisely because it is not absorbed. Oral peptides are normally a pharmaceutical problem, because the gut destroys them and almost nothing reaches the bloodstream.
Mechanism: A 14-amino-acid peptide agonist at guanylate cyclase-C on the apical surface of intestinal enterocytes, mimicking the endogenous peptides guanylin and uroguanylin. Activation raises intracellular and extracellular cyclic GMP, which activates the cystic fibrosis transmembrane conductance regulator chloride channel, driving chloride and bicarbonate into the lumen with sodium and water following.
Regulatory history: FDA-approved as Linzess for irritable bowel syndrome with constipation and for chronic idiopathic constipation in adults, and for functional constipation in children. Carries a boxed warning against use in children under two years because of a risk of serious dehydration.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Linaclotide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Linaclotide in other countries
Frequently asked questions
Is Linaclotide legal in the United States?
Yes. Linaclotide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: Approved for irritable bowel syndrome with constipation and chronic idiopathic constipation. Boxed warning contraindicating use in children under two years due to risk of serious dehydration.
Can I buy Linaclotide in the United States?
Only with a prescription. Linaclotide is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Approved for irritable bowel syndrome with constipation and chronic idiopathic constipation. Boxed warning contraindicating use in children under two years due to risk of serious dehydration.
Is Linaclotide FDA approved?
Yes. FDA status: FDA-approved as Linzess for irritable bowel syndrome with constipation and for chronic idiopathic constipation in adults, and for functional constipation in children. Carries a boxed warning against use in children under two years because of a risk of serious dehydration.. Current US classification: "FDA-approved, prescription only". On the evidence, 1 human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Linaclotide live on its compound profile.
Linaclotide profileThis page is general information about the regulatory status of Linaclotide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.